3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
21
Colonic Neoplasms
11
Rectal Neoplasms
10
Stomach Neoplasms
9
Esophageal Neoplasms
9
Pancreatic Neoplasms
8
Adenocarcinoma Of Esophagus
8
Cholangiocarcinoma
6
Neoplasm Metastasis
5
Lymphoma, Large B-Cell, Diffuse
5
Adenocarcinoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Ovarian Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Neoplasms
3
Gallbladder Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Hepatocellular
3
Biliary Tract Neoplasms
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lung Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
Magnetic Resonance Spectroscopy
7
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Temozolomide
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vincristine
2
Cyclophosphamide
2
Cisplatin
2
tazemetostat
1
pembrolizumab
1
palbociclib
1
lutetium Lu 177 dotatate
1
Vemurafenib
1
Vascular Endothelial Growth Factor A
1
Triiodothyronine
1
Thiotepa
1
Radiotherapy
1
Radiation
1
Platinum
1
Pharmacogenomic Variants
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Oxaliplatin
×
30 days
×
Clear all
No trials found.